Doctor profile · Federal record
Dr. Mark Cannon, M.D.
Psychiatry Physician (CMS: Psychiatry) · Kansas City, MO
- NPI 1720169295
- Accepts Medicare
- 42 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3801 Blue Pkwy
Kansas City, MO 641302807
(816) 922-7645
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1984 — 42 yrs since
- Specialty taxonomy
- 2084P0800X — NUCC code
- State license (1)
- Missouri #R7F32
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1720169295. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
132
Distinct HCPCS
2
Medicare allowed
$5,830
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 114 | 64 | $41 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 18 | 16 | $65 |
In context: peer comparison
Among 20 peers in Kansas City Psychiatry Physician, average services per provider: 94. This provider delivers 1.4× the peer median.Open Payments
Industry payments received
All-time total
$3,270
Transactions
186
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Alkermes, INC. | 25 | $440.63 | |
| Abbvie INC. | 27 | $393.44 | |
| Supernus Pharmaceuticals, INC. | 5 | $368.23 | |
| Teva Pharmaceuticals USA, INC. | 35 | $332.86 | |
| Otsuka America Pharmaceutical, INC. | 19 | $308.02 | |
| Neurocrine Biosciences, INC. | 11 | $229.33 | |
| Janssen Pharmaceuticals, INC | 8 | $206.65 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | 13 | $194.91 | |
| Axsome Therapeutics, INC. | 10 | $178.08 | |
| Vanda Pharmaceuticals INC. | 10 | $172.14 | |
| Lundbeck LLC | 9 | $149.33 | |
| Indivior INC. | 6 | $117.99 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $76.33 | |
| Noven Therapeutics, LLC | 3 | $55.84 | |
| Takeda Pharmaceuticals U.S.A., INC. | 1 | $25.65 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,189
Patients
610
Total drug cost
$424,640
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Quetiapine Fumarate | Generic | 572 | 76 | $22,927 |
| Clonazepam | Generic | 424 | 66 | $8,625 |
| Trazodone Hcl | Generic | 418 | 67 | $6,286 |
| Diazepam | Generic | 392 | 60 | $4,064 |
| Benztropine Mesylate | Generic | 335 | 39 | $4,531 |
| Olanzapine | Generic | 303 | 44 | $13,202 |
| Risperidone | Generic | 272 | 33 | $9,473 |
| Fluoxetine Hcl | Generic | 231 | 34 | $4,955 |
| Lorazepam | Generic | 221 | 34 | $3,164 |
| Duloxetine Hcl | Generic | 208 | 36 | $4,823 |
Frequently asked questions
What is Dr. Mark Cannon's medical specialty?
Dr. Mark Cannon practices Psychiatry Physician in Kansas City, MO.
Where does Dr. Mark Cannon practice?
Dr. Mark Cannon practices at 3801 Blue Pkwy, Kansas City, MO 641302807. Office phone: 8169227645.
What is Dr. Mark Cannon's NPI?
Dr. Mark Cannon's National Provider Identifier (NPI) is 1720169295, issued by NPPES.
Does Dr. Mark Cannon accept Medicare assignment?
Yes. Dr. Mark Cannon accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Cannon commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.